Haemodynamic effects of intravenous isosorbide-5-mononitrate in acute and chronic left heart failure of ischaemic aetiology

B. Rabinowitz, A. Katz, A. Shotan, P. Chouraqui, H. N. Neufeld

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

Isosorbide-5-mononitrate was administered in a continuous intravenous infusion, according to the haemodynamic response, to 19 patients with left heart failure of ischaemic aetiology; 12 with acute heart failure complicating an acute myocardial infarction and 7 with chronic ischaemic failure. In both groups, the following statistically significant haemodynamic changes were observed: a decrease in PCWP from 25.4 ± 4.6 to 17.2 ± 4.6 mmHg; an increase in SWI from 19.1 ± 10 to 23.6 ± 13.1 gm m-2; a slight increase in cardiac index with no change in arterial pressure and only minimal decrease in vascular resistance. There were two major differences in the haemodynamic response between the patients with acute heart failure and those with chronic disease: (a) the duration of the effect of isosorbide-5-mononitrate on the PCWP was longer in the first group (mean, 8 hours, compared to 1.5 hours in the chronic group), and (b) the effect on afterload was more pronounced in the group with chronic ischaemic failure than in the first group. Thus, isosorbide-5-mononitrate administered by intravenous infusion under careful monitoring appears to have a beneficial role in the treatment of acute as well as chronic ischaemic heart failure.

Original languageEnglish
Pages (from-to)175-180
Number of pages6
JournalEuropean Heart Journal
Volume9
Issue numberSUPPL. A
DOIs
StatePublished - 1 Jan 1988
Externally publishedYes

Fingerprint

Dive into the research topics of 'Haemodynamic effects of intravenous isosorbide-5-mononitrate in acute and chronic left heart failure of ischaemic aetiology'. Together they form a unique fingerprint.

Cite this